Agilent Technologies announced a $950 million acquisition of Biocare Medical, resulting in a notable 3.8% increase in its stock price during premarket trading. This strategic acquisition aims to bolster Agilent's position in the life sciences market, complementing its recent initiatives, including contracts with the U.S. TSA and the deployment of advanced technologies at major events like the FIFA World Cup. Headquartered in Santa Clara, California, Agilent supports over 285,000 laboratories worldwide, reinforcing its commitment to innovation and market expansion.
“Agilent Technologies · increased · premarket trading · +18.89%”
“Aa Aaaaaa · last · price · 55.82”
“Aa Aaaaaa · upside · upside · +72.02%”
“Aaa Aaaaaaaaaaaa · last · price · 244.10”
“Aaa Aaaaaaaaaaaa · upside · upside · +65.04%”
“Aaaaaaaa · last · price · 43.62”
“Aaaaaaaa · upside · upside · +63.42%”
“Aaaaaa Aaaaaa · last · price · 177.87”
“Aaaaaa Aaaaaa · upside · upside · +60.57%”
“Aaaa A · last · price · 282.02”
“Aaaa A · upside · upside · +56.17%”
“Aaaaaaaaaa · last · price · 176.31”